Pancreatectomies for Benign or Borderline Malignant Cystic Tumors of the Pancreas

概要

論文の詳細を見る
At present, benign or borderline malignant cystic tumors located in the head, uncus, body or tail of the pancreas that are not small and superficial enough to be enucleated are usually resected with a pancreatoduodenectomy (PD) or digital pancreatectomy (DP). Such operations may cause digestive disorders, glucose intolerance. Duodenum-preserving pancreatoduodenectomy (DpPHR), uncinate resection (UR), segmental pancreatectomy (SR) and spleenpreserving distall pancreatectomy (SpDP) are function-preserving procedures. The purpose of this study was to evaluate whether DpPHR, SR and SpDP were valuable procedures in pancreatic surgery. Patients were treated by DpPHR (n=7;1 serous cystadenoma, 1 mucinous cystadenoma, 5 intraductal papillary mucinous tumors), UR (n=1;1 intraductal papillary mucinous tumor), SR (n=4;1 solid and cystic tumor, 1 serous cystadenoma, 2 mucinous cystadenomas) and SpDP (n=7; 5 mucinous cystadenomas, 2 intraductal papillary mucinous tumors), There were no fatalities during or immediately following surgery. All patients but one were not glucose intolerance and digestive disorders.We believe that DpPHR, UR, SR and SpDP were minimally invasive procedures in pancreatic surgery;it is a reliable technique for benign or borderline malignant cystic tumors and has a surgical risk similar to that of standard operations. Its principal advantage is that it preserves pancreatic parenchyma, biliary tract and the spleen better than PD or DP